Skip to main content
SpringerLink
Log in

Porphyrias

  • Chapter
Management of Blistering Diseases

  • 74 Accesses

Abstract

The synthesis of haem is obligatory for all aerobic cells because of the importance of this prosthetic group for a variety of metabolic processes. It is an iron-chelated tetrapyrrole that facilitates electron-transfer reactions vital for energy exchange and also catalyses the introduction of molecular oxygen into a broad range of endogenous and exogenous substrates which assists in diminishing their biological activity and enhancing their rate of excretion from the body.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bickers, D.R. (1986) Porphyria: basic science aspects. Dermatol. Clin. North Amer., 4, 277–90.

    CAS  Google Scholar 

  2. Elder, G.H. (1986) Metabolic abnormalities in the porphyrias. Semin. Dermatol., 5, 88–98.

    Google Scholar 

  3. Kohn, K. and Kessel, D. (1979) On the mode of cytotoxic action of photoactivated porphyrins. Biochem. Pharmacol., 28, 2465–70.

    Article  CAS  PubMed  Google Scholar 

  4. Poh-Fitzpatrick, M.B. (1986) Molecular and cellular mechanisms of porphyrin photosensitization. Photo dermatology., 3, 148–57.

    CAS  PubMed  Google Scholar 

  5. Kerdel, F.A., Soter, N.A. and Lim, H.W. (1987) In vivo mediator release and degranulation of mast cells in hematoporphyrin derivative-induced phototoxicity in mice. J. Invest. Dermatol., 88, 277–80.

    Article  CAS  PubMed  Google Scholar 

  6. Pigatto, P., Altomare, G., Polenghi, M.M., et al. (1985) Role of the polymorphonuclear neutrophils in the phototoxic reaction in porphyria cutanea tarda. Photodermatology, 2, 372–6.

    CAS  PubMed  Google Scholar 

  7. Lim. H.W., Perez, H.D., Poh-Fitzpatrick, M.B., et al. (1981) Generation of chemotactic activity in serum from patients with erythropoietic protoporphyria and porphyria cutanea tarda. New Eng. J. Med., 304, 212–16.

    Article  CAS  PubMed  Google Scholar 

  8. Hawkins, C.W., Bickers, D.R., Mukhtar, H., et al. (1986) Cutaneous porphyrin photosensitization: Murine ear swelling as a marker of the acute response. J. Invest. Dermatol., 86, 638–42.

    Article  CAS  PubMed  Google Scholar 

  9. Athar, M., Elmets, C.A., Bickers, D.R. and Mukhtar, H. (1989) A novel mechanism for the generation of Superoxide anion in hematoporphyrin derivative-mediated cutaneous photosensitization activation of the xanthine oxidase pathway. J. Clin. Invest., 83, 1137–43.

    Article  CAS  PubMed  Google Scholar 

  10. Nordmann, Y. and Deybach, J.C. (1986) Congenital erythropoietic porphyria. Semin. Dermatol., 5, 106–14.

    Google Scholar 

  11. Murphy, G. M., Hawk, J.L.M., Nicholson, D.C., et al. (1987) Congenital erythropoietic porphyria (Gunther’s disease). Clin. Exp. Dermatol., 12, 61–5.

    Article  CAS  PubMed  Google Scholar 

  12. Romeo, G. and Levin, E.Y. (1969) Uroporphyrinogen III cosynthetase in human congenital erythropoietic porphyria. Proc. Natl. Acad. Sci. U.S.A., 63, 856–63.

    Article  CAS  PubMed  Google Scholar 

  13. Kramer, S., Viljoen, E., Meyer, A.M., et al. (1965) The anemia of erythropoietic porphyria with the first description of the disease in an elderly patient. Brit. J. Haematol., 11, 666–75.

    Article  CAS  Google Scholar 

  14. Romea, G., Glenn, B.L. and Levin, E.Y. (1970) Uroporphyrinogen cosythetase in asymptomatic carriers of congenital erythropoietic porphyria. Biochem. Genet., 4, 719–26.

    Article  Google Scholar 

  15. Eisen, A.Z. (1969) Human skin collagenase: Relationship to pathogenesis of epidermolysis bullosa dystrophica. J. Invest. Dermatol., 52, 449–53.

    CAS  PubMed  Google Scholar 

  16. Grandchamp, B., Deybach, J.C., Grelier, M., et al. (1980) Studies of porphyrin synthesis in fibroblasts of patients with congenital erythropoietic porphyria and of a case of homozygous coproporphyria. Biochim. Biophys. Acta, 629, 577–86.

    Article  CAS  PubMed  Google Scholar 

  17. Sassa, S. and Kappas, A. (1981) in Advances in Human Genetics, Vol. 11 (eds H. Harris and K. Hirschorn), Plenum Press, New York, pp. 121–231.

    Google Scholar 

  18. Haining, R.C., Cowger, M.C., Shurtleff, D.B., et al. (1968) Congenital erythropoietic porphyria I. Case report, special studies and therapy. Amer. J. Med., 45, 624–37.

    Article  CAS  PubMed  Google Scholar 

  19. Tsai, S.F., Bishop, D.F. and Desnick, R.J. (1987) Coupled-enzyme and direct assays for uroporphyrinogen III synthase activity in human erythrocytes and cultures lymphoblasts. Enzymatic diagnosis of heterozygotes and homogygotes with congenital erythropoietic porphyria. Anal. Biochem., 166, 120–33.

    Article  CAS  PubMed  Google Scholar 

  20. Sneddon, I.B. (1978) β-carotene in congenital porphyria. Arch. Dermatol., 114, 1242–3.

    Article  CAS  PubMed  Google Scholar 

  21. Aldrich, R.A., Hawkinson, V., Grinstein, M., et al. (1951) Photosensitive or congenital porphyria with hemolytic anemia. I. Clinical and fundamental studies before and after splenectomy. Blood, 6, 685–98.

    CAS  PubMed  Google Scholar 

  22. Haining, R.C., Lowger, M.L., Labbe, R.F., et al. (1970) Congenital erythropoietic porphyria II. The effects of induced polycythemia. Blood, 36, 297–309.

    CAS  PubMed  Google Scholar 

  23. Piomelli, S., Poh-Fitzpatrick, M.B., Seaman, C., et al. (1986) Complete suppression of the symptoms of congenital erythropoietic porphyria by long-term treatment with high-level transfusions. New Engl. J. Med., 314, 1029–31.

    Article  CAS  PubMed  Google Scholar 

  24. Watson, C.J., Bossenmaier, I., Cardinal, R., et al. (1974) Repression by hematin of porphyrin biosynthesis in erythrocyte precursors in congenital erythropoietic porphyria. Proc. Natl Acad. Sci. U.S.A., 71, 278–82.

    Article  CAS  PubMed  Google Scholar 

  25. Lischner, H.W. (1966) Cholestryamine and porphyrin binding. Lancet, ii, 1079–80.

    Article  Google Scholar 

  26. Pimstone, N.R., Gandhi, S.N. and Mukerji, S.K. (1987) Therapeutic efficacy of oral charcoal in congenital erythropoietic porphyria. New Engl. J. Med., 316, 390–3.

    Article  CAS  PubMed  Google Scholar 

  27. Deybach, J.C., Grandchamp, B., Gselier, M., et al. (1980) Prenatal exclusion of congenital erythropoietic porphyria (Gunther’s disease) in a fetus at risk. Hum. Genet., 53, 217–21.

    CAS  PubMed  Google Scholar 

  28. Mascaro, J.M., Herrero, C., Lecho, M., et al. (1986) Uroporphyrinogen-decarboxylase deficiencies: Porphyria cutanea tarda and related conditions. Semin. Dermatol., 5, 115–24.

    Google Scholar 

  29. Cam, C. and Nigogosyan, G. (1963) Acquired toxic porphyria cutanea tarda due to hexachlorobenzene. Report of 348 cases caused by this fungicide. J. Amer. Med. Assoc., 183, 88–91.

    CAS  Google Scholar 

  30. Elder, G.H. (1976) The effect of the porphyrinogenic compound hexachlorobenzene, on the activity of hepatic uroporphyrinogen decarboxylase in the rate. Clin. Sci. Mol. Med., 51, 71–80.

    CAS  PubMed  Google Scholar 

  31. Cripps, D.J. (1987) Diet and alcohol effects on the manifestation of hepatic porphyrias. Fed. Proc., 46, 1894–1900.

    CAS  PubMed  Google Scholar 

  32. Mukerji, S.K., Pimstone, N.R. and Burns, M. (1984) Dual mechanism of inhibition of rat liver uroporphyrinogen decarboxylase activity by ferrous iron: its potential role in the genesis of porphyria cutanea tarda. Gastroenterology, 87, 1248–54.

    CAS  PubMed  Google Scholar 

  33. Elder, G.H. and Lee, G.B., (1978) Decreased hepatic uroporphyrinogen decarboxyase in porphyria cutanea tarda. New Engl. J. Med., 299, 274–8.

    Article  CAS  PubMed  Google Scholar 

  34. Verneuil, H. de, Aitken, G. and Nordmann, Y. (1978) Familial and sporadic porphyria cutanea: Two different diseases. Hum. Genet., 42, 145–51.

    Article  Google Scholar 

  35. Elder, G.H. (1986) Metabolic abnormalities in the porphyrias. Semin. Dermatol., 5, 88–98.

    Google Scholar 

  36. Elder, G.H., Sheppard, D.M., Tovey, J.A., et al. (1983) Immunoreactive uroporphyrinogen decarboxylase in porphyria cutanea tarda. Lancet, i, 1301–4.

    Article  Google Scholar 

  37. Verneuil, H. de, Beaumont, C., Deybach, J.C., et al. (1984) Enzymatic and immunological studies of uroporphyrinogen decarboxylase in familial porphyria cutanea tarda and hepatoerythropoietic porphyria. Amer. J. Hum. Genet., 36, 613–22.

    PubMed  Google Scholar 

  38. Verneuil, H. de, Grandchamp, B, Romeo, P.H., et al. (1986) Molecular analysis of uroporphyrinogen decarboxylase deficiency in a family with two cases of hepatoerythropoietic porphyria. J. Clin. Invest., 77, 431–5.

    Article  PubMed  Google Scholar 

  39. Verneuil, H. de, Grandchamp, B., Beaumont, C., et al. (1986) Uroporphvrinogen decarboxylase structural mutant (Gly281-Glu) in a case of porphyria. Science, 234, 732–4.

    Article  PubMed  Google Scholar 

  40. Fujita, H., Sassa, S., Toback, A.C., et al. (1987) Immunochemical study of uroporphyrinogen decarboxylase in a patient with mild hepatoerythopoietic porphyria. J. Clin. Invest., 79, 1533–7.

    Article  CAS  PubMed  Google Scholar 

  41. Toback, A.C., Sassa, S., Poh-Fitzpatrick, M.B., et al. (1987) Hepatoerythropoietic porphyria: Clinical, biochemical, and enzymatic studies in a three-generation family lineage. New Engl. J. Med., 316, 645–50.

    Article  CAS  PubMed  Google Scholar 

  42. Bickers, D.R. and Pathak, M.A. (1987) in Dermatology in General Medicine (eds T.B. Fitzpatrick, A. Eisen, K. Wolff, et al.), McGraw-Hill, New York, pp. 1666–715.

    Google Scholar 

  43. Judd, L.E., Henderson, D.W. and Hill, D.C. (1986) Naproxen-induced pseudoporphyria. A clinical and ultrastructural study. Arch. Dermatol., 122, 451–4.

    Article  CAS  PubMed  Google Scholar 

  44. Burry, J.N. and Lawrence, J.R. (1976) Phototoxic blisters from high frusemide dosage. Brit. J. Dermatol., 94, 495–9.

    Article  CAS  Google Scholar 

  45. Ramsay, C.A. and Obreshkova, E. (1974) Photosensitivity from nalidixic acid. Brit. J. Dermatol., 91, 523–8.

    Article  CAS  Google Scholar 

  46. Epstein, J.H., Tuffanelli, D.L., Subert, J.S., et al. (1976) Porphryia-like cutaneous changes induced by tetracycline hydrochloride photosensitization. Arch. Dermatol., 112, 661–6.

    Article  CAS  PubMed  Google Scholar 

  47. Howard, A.M., Dowling, J. and Varigos, G. (1985) Pseudoporphyria due to naproxen. Lancet, i, 819–20.

    Article  Google Scholar 

  48. Lamkin, B.C. and Bickers D.R. (1983) Porphyria cutanea tarda: A metabolic human blistering disease. Dermatol. Clin., 1 249–62.

    Google Scholar 

  49. Woodley, D.T., Burgeson, R.E., Lungstrum, G.P., et al. (1988) The epidermolysis bullosa acquisita antigen in the globular carboxyl terminus of Type VII procollagen. J. Clin. Invest., 81, 683–7.

    Article  CAS  PubMed  Google Scholar 

  50. Yaoita, H., Briggaman, R.A., Lawley, T.J., et al. (1981) Epidermolysis bullosa acquisita: Ultra-structural and immunological studies. J. Invest. Dermatol., 76, 288–92.

    Article  CAS  PubMed  Google Scholar 

  51. Wolff, K., Honigsmann, H., Rauschmeier, W., et al. (1982) Microscopic and fine structural aspects of porphyrias. Acta Dermatovenereol. Suppl., 100, 17–28.

    CAS  Google Scholar 

  52. Caputo, R., Berti, E. and Gasparini, G. (1983) The morphologic events of blister formation in porphyria cutanea tarda. Int. J. Dermatol., 22, 467–72.

    Article  CAS  PubMed  Google Scholar 

  53. Kint, A. (1970) Comparative electron microscopic study of the perivascular hyaline from porphyria cutanea tarda and from lipoid proteinosis. Arch. Klin. Exp. Dermatol., 239, 203–17.

    CAS  PubMed  Google Scholar 

  54. Epstein, J.H., Tuffanelli, D.L. and Epstein, W.L. (1973) Cutaneous changes in the porphyrias. Arch. Dermatol., 107, 689–98.

    Article  CAS  PubMed  Google Scholar 

  55. Klein, G.F., Hintner, H.F., Schüler, G., et al. (1983) Junctional blisters in acquired bullous disorders of the dermal/epidermal junction zone: Role of the lamina lucida as the mechanical locus minoris resistentiae. Brit. J. Dermatol., 109, 499–508.

    Article  CAS  Google Scholar 

  56. Pearson, R.W. (1967) in Ultrastructure of Normal and Abnormal Skin (ed. A.S. Zelickson), Lea and Febiger, Philadelphia, pp. 320–34.

    Google Scholar 

  57. Smith, S.G. (1986) Hepatoerythropoietic porphyria. Semin. Dermatol., 5, 125–37.

    Google Scholar 

  58. Verneuil, H. de, Sassa, S. and Kappas, A. (1983) Purification and properties of uroporphyrinogen decarboxylase from human erythrocytes. A single enzyme catalyzing the four sequential decarboxylations of uroporphyinogens I and III. J. Biol. Chem., 258, 2454–60.

    PubMed  Google Scholar 

  59. Elder, G.H., Smith, S.G., Herrero, C., et al. (1981) Hepatoerythropoietic porphyria: A new irp [pr] jurompgem decarboxylase defect or homozygous porphyria cutanea tarda. Lancet, 1, 916–19.

    Article  CAS  PubMed  Google Scholar 

  60. Brenner, D.A. and Bloomer, J.R. (1980) The enzymatic defect in variegate porphyria. Studies with cultured human skin fibroblasts. New Engl J. Med., 302, 765–9.

    Article  CAS  PubMed  Google Scholar 

  61. Deybach, J.C., de Vernueil, H. and Nordmann, Y. (1981) The inherited enzymatic defect in porphyria variegata. Hum. Genet., 58, 425–8.

    CAS  PubMed  Google Scholar 

  62. Nordmann, Y. and Deybach, J.C. (1982) Congenital erythropoietic porphyria. Semin. Liver Dis., 2, 154–63.

    Article  CAS  PubMed  Google Scholar 

  63. Mukerji, S.K., Pimstone, N.R. and Burns, M, (1984) Dual mechanism of inhibition of rat liver uroporphyrinogen decarboxylase activity by ferrous iron: Its potential role in the genesis of porphyria cutanea tarda. Gastroenterology, 87, 1248–54.

    CAS  PubMed  Google Scholar 

  64. Bruguera, M. (1986) Liver involvement in porphyria. Semin. Dermatol., 5, 178–85.

    Google Scholar 

  65. Grossman, M.E. and Bickers, D.R. (1978) Porphyria cutanea tarda: A rare manifestation of hepatic tumors. Cutis, 21, 782–4.

    CAS  PubMed  Google Scholar 

  66. Topi, G.C., Gandolfo, L.D., De Costanza, F., et al. (1980) Porphyria cutanea tarda and hepatocellular carcinoma. Int. J. Biochem., 12, 883–5.

    Article  CAS  PubMed  Google Scholar 

  67. Muhlbauer, J.E. and Pathak, M.A. (1979) Porphyria cutanea tarda. Int. J. Dermatol., 18, 767–80.

    Article  CAS  PubMed  Google Scholar 

  68. Hetherington, G.W., Jelton, R.L., Know, J.M., et al. (1970) The association of lupus erythmatosus and porphyria. Brit. J. Dermatol., 82, 118–24.

    Article  CAS  Google Scholar 

  69. Day, R.S. (1986) Variegate porphyria. Semin. Dermatol., 5, 138–54.

    Google Scholar 

  70. Day, R.S., Eales, L. and Meissner, D. (1982) Coexistent variegate porphyria and porphyria cutanea tarda. New Engl. J. Med., 307, 36–41.

    Article  CAS  PubMed  Google Scholar 

  71. Ippen, H. (1961) Allgemeinsymptome der spaten Hautporphyrie (PCT) als Hinweise fur deren Behandlung. Dtsch. Med. Wschr., 86, 127–33.

    Article  CAS  PubMed  Google Scholar 

  72. Cripps, D.J. and Curtis, A.C. (1962) Toxic effect of chloroquine on porphyria hepatica. Arch. Dermatol., 86, 575–81.

    Article  Google Scholar 

  73. Bickers, D.R. and Merk, H. (1986) The treatment of porphyrias. Semin. Dermatol., 5, 186–97.

    Google Scholar 

  74. Ramsay, CA., Magnus, I. A., Turnbull, A., et al. (1974) The treatment of porphyria cutanea tarda by venesection. Q. J. Med., 43, 1–13.

    CAS  PubMed  Google Scholar 

  75. Lundvall, O. (1971) The effect of replenishment of iron stores after phlebotomy therapy in porphyria cutanea tarda. Acta Med. Scand., 1–2, 51–63.

    Google Scholar 

  76. Malina, L. (1986) Treatment of chronic hepatic porphyria (PCT). Photo dermatology., 3, 113–21.

    CAS  PubMed  Google Scholar 

  77. Felscher, B.F. and Redeker, A.G. (1966) Effect of chloroquine or hepatic uroporphyrin metabolism in patients with porphyria cutanea tarda. Medicine, 45, 575–82.

    Article  Google Scholar 

  78. Kowertz, M. (1973) The therapeutic effect of chloroquine. Hepatic recovery in porphyria cutanea tarda. J. Amer. Med. Assoc., 223, 515–19.

    CAS  Google Scholar 

  79. Saltzer, E., Redeker, A.G. and Wilson, J.W. (1968) PCT remission following chloroquine without adverse effects. Arch. Dermatol., 98, 496–8.

    Article  CAS  PubMed  Google Scholar 

  80. Kordac, V. and Semradova, M. (1974) Treatment of porphyria cutanea tarda with chloroquine. Brit. J. Dermatol., 90, 95–100.

    Article  CAS  Google Scholar 

  81. Scholnick, P.L., Epstein, J.H. and Marver, H.S. (1973) The molecular basis of the action of chloroquine in porphyria cutanea tarda. J. Invest. Dermatol., 61, 226–32.

    Article  CAS  PubMed  Google Scholar 

  82. Taljaard, J.J.F., Shanley, B.C., Stewart-Wynne, E.G., et al. (1972) Studies on low dose chloroquine therapy and the action of chloroquine in symptomatic porphyria. Brit. J. Dermatol., 87, 261–9.

    Article  CAS  Google Scholar 

  83. Swanbeck, G. and Wennersten, G. (1977) Treatment of porphyria cutanea tarda with chloroquine and phlebotomy. Brit. J. Dermatol., 97, 77–82.

    Article  CAS  Google Scholar 

Download references

Authors
  1. David R. Bickers
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. The Slade Hospital, Oxford, UK

    Fenella Wojnarowska

  2. University of North Carolina School of Medicine, Chapel Hill, USA

    Robert A. Briggaman

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Bickers, D.R. (1990). Porphyrias. In: Wojnarowska, F., Briggaman, R.A. (eds) Management of Blistering Diseases. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-7190-6_19

Download citation

  • DOI: https://doi.org/10.1007/978-1-4899-7190-6_19

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-412-28990-3

  • Online ISBN: 978-1-4899-7190-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation